echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Taking stock of the report on the financing trends of the healthcare industry in the first half of the year, where did all the money in the venture capital circle go?

    Taking stock of the report on the financing trends of the healthcare industry in the first half of the year, where did all the money in the venture capital circle go?

    • Last Update: 2021-08-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    [Financing Overview] From January to June, a total of 578 investment and financing events occurred in the medical and health sector across the country, with a cumulative amount exceeding 115.


    172 billion yuan



    [Regional distribution of financing] The financing projects from January to June were mainly distributed in Shanghai (138 cases) and Beijing (105 cases)
    .


    Among them, the financing amount in Guangdong Province was as high as 30.
    473 billion yuan, accounting for 26.
    46% of the total financing amount



    [Distribution of financing amount] A total of 578 projects received investment from January to June, with a cumulative amount exceeding 115.


    172 billion yuan, and 289 cases where a single financing amount exceeded 100 million yuan.



    [The most popular field for investors] The medical device field attracted the most money in the first half of the year, with the financing amount exceeding 37.


    179 billion yuan, accounting for 32.
    28% of the total financing amount



    The most noteworthy financing project

    1.


    Siemens Healthineers AG successfully alloted 53 million new shares to institutional investors through accelerated bookkeeping additional issuance


    "Through this allotment, we successfully completed the equity-related part of Varian Finance and implemented the financing structure originally announced," said Dr.
    Jochen Schmitz, Chief Financial Officer of Siemens Medical Group
    .


    "The transaction will also increase free float, thereby increasing the attractiveness of our stocks
    .
    " 2.
    On February 9, Beijing Yuanxin Technology Group (hereinafter referred to as Yuanxin Technology) officially announced the completion of 3 billion yuan in Series E financing
    .
    This round is another round of financing six months after the completion of the D round of financing in June 2020.
    It was jointly led by Sequoia Capital China Fund and Tencent.
    CITIC Securities, CICC Capital, OrbiMed, Qiming Venture Capital, Kunhui Capital, and Ge Fiji Asset, E Fund, Index Capital, etc.
    participated in the investment, and Index Capital continued to act as the exclusive financial advisor
    .

    This round of investors includes multiple types of top institutions, including primary and secondary markets, TMT and the medical industry, industrial capital and financial capital, forming a cross-perspective capital consensus
    .

    After this round of financing, Yuanxin Technology will continue to dig deep into its service capabilities and use funds to enhance the company's competitive advantages in the fields of Internet medical care, medication management, and health insurance, and further consolidate the company's "doctor-patient-medicine-insurance" ecological service advantage
    .
    3.
    On February 25, WeDoctor Holdings (hereinafter referred to as "WeDoctor"), a digital medical platform spin-off by WeDoctor Group, has recently completed more than US$400 million in Pre-IPO financing, with a valuation of nearly US$7 billion , The company may submit an IPO application to the Hong Kong Stock Exchange as soon as next month
    .

    This round of financing of WeDoctor is mainly supported by old shareholders represented by Sequoia Capital, and strategic investments by investment institutions such as Millennium Capital and large insurance institutions
    .
    It is worth mentioning that WeDoctor is the first Pre-IPO round project that Millennium Capital has participated in in Asia
    .

    It is understood that, relying on Internet hospitals, the digitally responsible medical system created by WeDoctor is being implemented in Shandong, Tianjin and other regions and is being replicated in other regions across the country on a large scale
    .
    In Tianjin, WeDoctor has created China’s first provincial-level close medical consortium led by an Internet hospital.
    Its Internet hospital leads and collaborates with 267 primary-level medical institutions in the city to provide users with comprehensive services before, during and after the diagnosis.
    Process medical and health maintenance services, and implement a health responsibility system
    .
    4.
    Sports technology company Keep has recently completed 360 million U.
    S.
    dollars in Series E financing, with a post-investment valuation of 2 billion U.
    S.
    dollars, which is double the value of 1 billion U.
    S.
    dollars in Keep’s last round of financing in May 2020
    .
    This round of financing was led by the SoftBank Vision Fund, Hillhouse Capital and Kotu Capital followed suit, and old shareholders such as GGV, Tencent, Wuyuan Capital, Times Capital and BAI Capital also made additional investments
    .

    After this round of financing, Keep will also iteratively upgrade smart hardware such as treadmills and sports bracelets in 2021, continue to optimize the category of small sports equipment, and launch healthy foods that are more in line with the stomachs of Chinese consumers
    .

    List of financing events in the first half of the year

    Active investment institutions in the healthcare industry this week: Hillhouse Ventures, Sequoia Capital China, Tongchuangweiye, Qiming Ventures, Sherpa Investment, Matrix Partners China, Huagai Capital

    Table 1: List of financing events in the healthcare industry in the first half of the year



    Source: Flint Creation Database

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.